Female doctor with a stethoscope advising a clinical trial participant.

Immunic Therapeutics

Developing Selective
Oral Drugs in Immunology

Immunic is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases.

About Us

Advanced Development Pipeline

Differentiated Programs in Clinical Development

We are developing orally administered, small molecule programs, each of which has unique features intended to directly address the unmet needs of patients with serious chronic inflammatory and autoimmune diseases.

Treating Multiple Sclerosis

Elevate the Standard of Care With a Holistic Solution for Multiple Sclerosis Patients

Our mission is to develop high-quality, oral treatment options with comprehensive therapeutic efficacy and outstanding safety and tolerability for patients with multiple sclerosis.

Treating Celiac Disease

Making New, Convenient, Oral Treatment Options Available to Celiac Disease Patients

We aim to offer new, efficacious, safe and well-tolerated orally available treatment options to patients suffering from celiac disease in order to improve their lives by eliminating the debilitating symptoms of the disease.

Latest News

View All
“My life’s work revolves around leading companies to successfully develop and commercialize therapeutics that vastly improve the lives of patients suffering from debilitating diseases. Demanding excellence is paramount to success.”
Dr. Daniel Vitt
Chief Executive Officer and Director
“I have been so fortunate to spend my professional career in the pharmaceutical industry, where I have had the opportunity to positively impact the lives of countless human beings living with serious diseases. There is nothing more rewarding than developing a new medicine and can bring hope where there was no hope. This is our ultimate goal here at Immunic, to address unmet needs for individuals living with chronic inflammatory and autoimmune diseases.”
Jason Tardio
President and Chief Operating Officer
“It is my passion to work with emerging companies to develop ground-breaking technologies. Dedicated, dynamic teams can achieve a lot together when they share mutual respect and empower each other to bring out their best. Or, as the old African proverb says: If you want to go fast, go alone. If you want to go far, work together.”
Dr. Andreas Muehler
Chief Medical Officer
“Beautiful science should be translated into a better life for patients, otherwise, it’s still beautiful, but useless.”
Dr. Hella Kohlhof
Chief Scientific Officer
“It is my passion to be a member of an emerging company working with a team of extremely talented people, all focused in the same direction, with the goal of bringing life changing therapies to patients.”
Glenn Whaley
Chief Financial Officer
“Having a positive impact on patients’ lives is the ultimate objective. As a team, we must seize the opportunities to maximize the potential of our programs so that we may also maximize the benefits for patients.“
Patrick Walsh
Chief Business Officer
“My focus is, not only, to review and approve documents but to collaborate with my amazing colleagues in order to make a substantial impact for patients while creating long-term value for our investors and other stakeholders.”
Inderpal Singh
General Counsel
“I have a personal, long-lasting commitment to make every day count for those who need it most. I am, therefore, grateful that at Immunic we have an innate sense of urgency to make a difference, turning scientific breakthroughs into therapies that offer hope, improved health outcomes and meaningful improvements that change patients’ lives.”
Werner Gladdines
Chief Development Officer
“I am truly honored to work with such a high-powered team on the pursuit of exciting new science. We aim to bring novel and meaningful therapeutic options to doctors and their patients with devastating inflammatory and auto-immune conditions. Each of our drug candidates is potentially best-in-class and targets a product profile designed to improve patients’ lives by combining the convenience of oral delivery, with robust efficacy and patient-friendly tolerability.“
Dr. Duane Nash
Executive Chairman

Questions?

Get in touch.

Send an Email
Immunic, Inc. (Nasdaq: IMUX) Stock Quote:
Currency in USD. Quote data delayed at least 15 minutes.
Citeline Awards 2024 Finalist Icon. Most Successful Early Phase Research (Preclinical & Phase 1)Business Excellence Certificate, The BIZZ Awards Winner in Gold2023 International Business Awards Gold Icon2023 American Business Awards Gold Icon2023 German Stevie Awards Gold Winner Icon2023 German Stevie Awards Gold Winner IconBioTech Breakthrough Award Winner2023 American Business Awards Silver Icon2023 Stevie Awards for Women in Business Silver Icon2023 German Stevie Awards Bronze Icon2023 American Business Awards Bronze IconEuropean Lifestars Awards 2023 Finalist IconIR Magazine Award Nominee Icon
Business Excellence Certificate, The BIZZ Awards Winner in Gold

The BIZZ Awards

Winner

‘Business Excellence’

for being a leading company that has consistently demonstrated business excellence

Citeline Awards 2024 Finalist Icon. Most Successful Early Phase Research (Preclinical & Phase 1)

Citeline Awards 2024

Finalist

‘Most Successful Early Phase Research (Preclinical & Phase I)’

for the IMU-856 development program

2023 International Business Awards Gold Icon

2023 International Business Awards®

Gold

‘Conferences & Meetings
– Medical Congress’

for MS R&D webcast held in November 2022

2023 Stevie Awards for Women in Business Silver Icon

Stevie® Awards for Women in Business

Silver

‘Women in Healthcare’

for Dr. Hella Kohlhof, Chief Scientific Officer

European Lifestars Awards 2023 Finalist Icon

European Lifestars Awards 2023

Finalist

„Post-IPO Equity Raise of the Year“

IR Magazine Award Nominee Icon

IR Magazine Awards US 2022

Finalist

„Best IR Website“

2023 American Business Awards Gold Icon

2023 American Business Awards®

Gold

‘Conferences & Meetings  – Medical Congress’ 

‘Conferences & Meetings  – Scientific Congress’

for MS R&D webcast held in November 2022

2023 American Business Awards Silver Icon

2023 American Business Awards®

Silver

‘Achievement in Diversity & Inclusion’

for newly designed, accessibility-friendly website

BioTech Breakthrough Award Winner

2023 BioTech Breakthrough Awards

Winner

‘Developmental Immunology Solution of the Year’

for the IMU-856 development program

2023 German Stevie Awards Bronze Icon

German Stevie® Awards

Bronze

‘Special Achievement in Diversity & Inclusion’

for newly designed, accessibility-friendly website

2023 German Stevie Awards Gold Winner Icon

2023 German Stevie® Awards

Gold

‘Best Medical Event’ 

‘Best B2B Event’

for MS R&D webcast held in November 2022

2023 German Stevie Awards Gold Winner Icon

2023 German Stevie® Awards

Gold

‘Best Overall Design’

for newly designed, accessibility-friendly website

2023 American Business Awards Bronze Icon

2023 American Business Awards®

Bronze

‘Corporate & Community – B2B Event’

for MS R&D webcast held in November 2022